Pharmaceutical Technology, Mar 2, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Mar 2, 2010
Online Exclusives
Opportunities in the Biosimilars Market
By Patricia Van Arnum
Analysis of the opportunities and challenges in the biosimilars market.
Strategic Sourcing Focuses on Risk Mitigation
By Patricia Van Arnum
Pharmaceutical companies and their suppliers share approaches in risk mitigation in sourcing and ways to optimize the outsourced relationship.
Special Report
In Search of a Sterile Fill
By Erik Greb
Technological developments make it easier to manufacture sterile parenterals.
Ingredients Insider
Navigating the Global Pharmaceutical Supply Chain
By Patricia Van Arnum
Emerging markets remain an important element in the strategies of pharmaceutical companies and their suppliers.
Peer-Reviewed Research
Spherical Crystallization for Lean Solid-Dose Manufacturing (Part 1)
By Tu Lee , Yan Chan Su , Hung Ju Hou , Hsiang Yu Hsieh
In Part I of this article, the authors describe the materials and methods used in developing a screening strategy to accelerate the preparation and characterization of spherical agglomerates by spherical crystallization.
Statistically Justifiable Visible Residue Limits
By M. Ovais
Current methods for establishing visible residue limits (VRLs) are not statistically justifiable. The author proposes a method for estimating VRLs based on logistic regression.
From The Editor
Skinny or Dead
By Michelle Hoffman
If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.
PharmTech Talk
Uptick or Sustainable Growth?
By Patricia Van Arnum
Contract manufacturers report improving business conditions, but will they continue?
Agent-in Place
Quick Saves and Near Misses
By Control, a senior compliance officer
From last-minute product inserts to putting out fires, close calls are a common occurrence.
News
Report from India
By A. Nair
Could President Obama's tax reform, which is targeted at reducing outsourcing, endanger India's contract-services industry?
In the Spotlight
In the Spotlight
Editors' Picks of Pharmaceutical Science & Technology Innovations
Washington Report
Health IT Promises More Timely Drug Information
By Jill Wechsler
FDA modernizes information systems, expands access to drug safety and use information.
Packaging Forum
It's Showtime!
By Hallie Forcinio
Visitors to INTERPHEX 2010 will find an abundance of packaging innovations. Plus: Check out our preliminary program for LIVE video interviews at the show.
Outsourcing Outlook
Time for a Model Upgrade
By Jim Miller
CMOs' business model has all of the flaws of the captive model it is meant to replace.
Inside IPEC-Americas
Inside IPEC: Excipient Pedigree as a Supply Chain Tool
By Arthur J. Falk, PhD
It's time to maintain a thorough traceable excipient trail.
Pharma Capsules
Pharma Capsules
Brief pharmaceutical news items for March 2010.
Industry Pipeline
Industry Pipeline
Pre-Interphex 2010 Product Releases.
Viewpoint
Consumers Need Access to Lower-Cost Biogenerics
By Kathleen Jaeger
To best carry out the vision of Hatch-Waxman, Congress must act now on biogenerics.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here